Your browser doesn't support javascript.
loading
Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013.
Kinross, Pete; Petersen, Andreas; Skov, Robert; Van Hauwermeiren, Evelyn; Pantosti, Annalisa; Laurent, Frédéric; Voss, Andreas; Kluytmans, Jan; Struelens, Marc J; Heuer, Ole; Monnet, Dominique L.
Afiliação
  • Kinross P; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Petersen A; Statens Serum Institut, Copenhagen, Denmark.
  • Skov R; European Programme for Public Health Microbiology (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Van Hauwermeiren E; Statens Serum Institut, Copenhagen, Denmark.
  • Pantosti A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Laurent F; National Institute of Health, Rome, Italy.
  • Voss A; International Center for Infectiology Research (CIRI), INSERM, Lyon, France.
  • Kluytmans J; Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Struelens MJ; University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Heuer O; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Monnet DL; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Euro Surveill ; 22(44)2017 11.
Article em En | MEDLINE | ID: mdl-29113628
ABSTRACT
Currently, surveillance of livestock-associated meticillin-resistant Staphylococcus aureus (LA-MRSA) in humans in Europe is not systematic but mainly event-based. In September 2014, the European Centre for Disease Prevention and Control (ECDC) initiated a questionnaire to collect data on the number of LA-MRSA from human samples (one isolate per patient) from national/regional reference laboratories in European Union/European Economic Area (EU/EEA) countries in 2013. Identification of LA-MRSA as clonal complex (CC) 398 by multilocus sequence typing (MLST) was preferred, although surrogate methods such as spa-typing were also accepted. The questionnaire was returned by 28 laboratories in 27 EU/EEA countries. Overall, LA-MRSA represented 3.9% of 13,756 typed MRSA human isolates, but it represented ≥ 10% in five countries (Belgium, Denmark, Spain, the Netherlands and Slovenia). Seven of the reference laboratories did not type MRSA isolates in 2013. To monitor the dispersion of LA-MRSA and facilitate targeted control measures, we advocate periodic systematic surveys or integrated multi-sectorial surveillance.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Reservatórios de Doenças / Staphylococcus aureus Resistente à Meticilina / Gado / Doenças dos Animais Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Reservatórios de Doenças / Staphylococcus aureus Resistente à Meticilina / Gado / Doenças dos Animais Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article